FLAG chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FLAG chemotherapy, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia [Phase 1]